Skip to main content
logo
Hikma Pharmaceuticals PLC (HKMPF)
OTCMKTS · Delayed Price · Currency is USD
20.69
-1.61 (-7.20%)
At close: Feb 6, 2026

Hikma Pharmaceuticals Revenue

Hikma Pharmaceuticals had revenue of $1.66B in the half year ending June 30, 2025, with 16.19% growth. This brings the company's revenue in the last twelve months to $3.22B, up 6.60% year-over-year. In the year 2024, Hikma Pharmaceuticals had annual revenue of $3.13B with 8.77% growth.

Revenue (ttm)
3.22B
Revenue Growth
+6.60%
P/S Ratio
1.46
Revenue / Employee
338.53K
Employees
9,500
Market Cap
4.69B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20243.13B252.00M8.77%
Dec 31, 20232.88B358.00M14.22%
Dec 31, 20222.52B-36.00M-1.41%
Dec 31, 20212.55B212.00M9.06%
Dec 31, 20202.34B134.00M6.07%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sofgen Pharma423.75M
Jushi Holdings260.43M
Glass House Brands196.17M
MariMed157.38M
Elite Pharmaceuticals122.89M
Earth Science Tech33.84M
Radnostix14.07M
Healthy Extracts3.59M
Revenue Rankings

Hikma Pharmaceuticals News

More News